Wave Life Sciences (WVE) stock drops as updated results from an early-stage trial for the company;s obesity drug WVE-007 missed analysts' expectations. Read more here.
Wave plunges as analysts react to obesity data (WVE:NASDAQ)
Wave Life Sciences (WVE) stock drops as updated results from an early-stage trial for the company;s obesity drug WVE-007 missed analysts' expectations. Read more here.